IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Oracle Investment Management Inc

Q2 2025 Holdings

Filed 2025-08-15 | 14 holdings | $145.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Genedx Holdings Corp(WGS)COM CL A81663L200$85.2M922,45458.4%
Biohaven LTD(BHVN)COMG1110E107$9.5M673,1666.5%
Genedx Holdings CorpCallCALL81663L900$9.2M100,0006.3%
Springworks Therapeutics IncCallCALL85205L907$7.0M150,0004.8%
Teladoc Health IncCallCALL87918A905$6.5M750,1004.5%
Ardelyx Inc(ARDX)COM039697107$5.6M1,430,7283.8%
Ardelyx IncCallCALL039697907$4.6M1,179,8003.2%
Palantir Technologies Inc(PLTR)CL A69608A108$4.0M29,5002.8%
Quidelortho Corp(QDEL)COM219798105$3.4M118,2912.3%
Teladoc Health Inc(TDOC)COM87918A105$3.3M381,0002.3%
Biohaven LTD(BHVN)CallCALLG1110E907$2.8M200,0001.9%
Forian Inc(FORA)COM34630N106$2.7M1,366,1071.8%
Cava Group Inc(CAVA)COM148929102$1.6M18,6001.1%
Biogen Inc(BIIB)COM09062X103$302.9K2,4120.2%